B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 330 KRW
Market Cap: 116B KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+22%
Operating Income
Forecast
+32%
Net Income
Forecast
+38%

Wall Street
Price Targets

Price Targets Summary
Bio-FD&C Co Ltd

Wall Street analysts forecast Bio-FD&C Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Bio-FD&C Co Ltd is 20 400 KRW with a low forecast of 20 200 KRW and a high forecast of 21 000 KRW.

Lowest Forecast
Wall Street Target
20 200 KRW
52% Upside
Average Forecast
Wall Street Target
20 400 KRW
53% Upside
Highest Forecast
Wall Street Target
21 000 KRW
58% Upside
Lowest
Price Target
20 200 KRW
52% Upside
Average
Price Target
20 400 KRW
53% Upside
Highest
Price Target
21 000 KRW
58% Upside
Bio-FD&C Co Ltd Competitors:
Price Targets
302440
SK Bioscience Co Ltd
31% Upside
ORKA
Oruka Therapeutics Inc
372% Upside
P
214450
PharmaResearch Co Ltd
4% Downside
MIRM
Mirum Pharmaceuticals Inc
71% Upside
302440
SK Bioscience Co Ltd
31% Upside
ORKA
Oruka Therapeutics Inc
372% Upside
P
214450
PharmaResearch Co Ltd
4% Downside
MIRM
Mirum Pharmaceuticals Inc
71% Upside
A
APGE
Apogee Therapeutics Inc
198% Upside
Z
ZBIO
Zenas Biopharma Inc
295% Upside
PAR
Paradigm Biopharmaceuticals Ltd
177% Upside
EXEL
Exelixis Inc
5% Upside

Revenue
Forecast

Revenue Estimate
Bio-FD&C Co Ltd

For the last 4 years the compound annual growth rate for Bio-FD&C Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 14%.

16%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Bio-FD&C Co Ltd

For the last 4 years the compound annual growth rate for Bio-FD&C Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 19%.

15%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Bio-FD&C Co Ltd

For the last 4 years the compound annual growth rate for Bio-FD&C Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 12%.

22%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Bio-FD&C Co Ltd's stock price target?
Price Target
20 400 KRW

According to Wall Street analysts, the average 1-year price target for Bio-FD&C Co Ltd is 20 400 KRW with a low forecast of 20 200 KRW and a high forecast of 21 000 KRW.

What is Bio-FD&C Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 4 years the compound annual growth rate for Bio-FD&C Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 14%.

What is Bio-FD&C Co Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Bio-FD&C Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 19%.

What is Bio-FD&C Co Ltd's Net Income forecast?
Projected CAGR
12%

For the last 4 years the compound annual growth rate for Bio-FD&C Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 247,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.